Search
for
Sort by
Research 331–360 of 777
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hirsutism: Diagnosis and management
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Redefining hormone resistance in prostate cancer
- Current evaluation of amenorrhea
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Gender-Affirming Hormone Therapy for Transgender Females
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Endocrine evaluation of hirsutism
- Bone density is normal in male rats treated with finasteride.
- Gender-Affirming Hormone Therapy for Transgender Men
- The rationale for physiological testosterone replacement in women
- Androgenetic Alopecia: In Vivo Models
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Hirsutism: diagnosis and treatment
- Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene.
- Male hormonal contraception: looking back and moving forward
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Is polycystic ovary syndrome a sexual conflict? A review
- Female Adolescent Hair Disorders
- Hypothalamic DNA methylation in rats with dihydrotestosterone‐induced polycystic ovary syndrome: effects of low‐frequency electro‐acupuncture